COVID-19 Updates
Conference Coverage
Pandemic worsens disparities in GI and liver disease
Creative local solutions are needed to address screening and health care problems.
News from the FDA/CDC
FDA expands remdesivir use for all COVID-19 hospitalized patients
An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low...
News
FDA authorizes convalescent plasma for COVID-19
The authorization allows the plasma to be distributed in the U.S. and administered by health care providers.
Latest News
Severe obesity ups risk for death in younger men with COVID-19
These findings show that “obesity is an important independent risk factor for serious COVID-19 disease,” said Dr. David A. Kass.
Latest News
FDA authorizes new saliva COVID-19 test
“Providing this type of flexibility for processing saliva samples to test for COVID-19 infection is groundbreaking in terms of efficiency and...
Feature
PPE shortage could last years without strategic plan, experts warn
“If we had a more coordinated response with a partnership between the medical field, the government and the private industry, it would help...
The New Gastroenterologist
Web-based fellowship interviews in the era of COVID 19: Tips and tricks
Fellowship interviews are an essential step - arguably the most important step - in the process of matching candidates to training programs.
Latest News
One-third of outpatients with COVID-19 are unwell weeks later
“This should impact the perception of this being a mild illness in the young adult population and encourage them to comply with recommendations of...
From the Journals
Rapid drop of antibodies seen in those with mild COVID-19
“Our paper is the first to put firm numbers on the dropping of antibodies after early infection.”
From the Journals
Even mild obesity raises severe COVID-19 risks
People with BMI of 30 kg/m2 or higher are at increased risk for severe illness, while BMI of 35 or greater dramatically increases the...